| abstract |
The present invention relates to a pharmaceutical composition for treating and preventing inflammatory diseases or arthritis, which contains 2,4-bis (p-hydroxyphenyl) -2-butenal or a pharmaceutically acceptable salt thereof as an active ingredient. More specifically, 2,4-bis (p-hydroxyphenyl) -2-butenal of the present invention is lipopolysaccharide (LPS) -induced reactive oxygen species (ROS), nitric oxide (NO) or prostaglandin E. 2 (PGE 2 ) to inhibit the production of a inflammatory disease, characterized in that the pharmaceutical composition. |